NorthRock Partners’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
BIP
NAMI
NorthRock Partners's ABEV Position: Q1 2026 in Review
NorthRock Partners reduced its Ambev (ABEV) stake by 13% in Q1 2026, selling an estimated $5.92K and leaving 13,760 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #662.
NorthRock Partners first reported a position in ABEV in Q3 2025 and has held it in 3 quarters since. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.
- NorthRock Partners held 13,760 shares of Ambev worth $40.2K as of Q1 2026.
- NorthRock Partners sold 2,073 Ambev shares in Q1 2026, an estimated $5.92K.
- Ambev made up ﹤0.01% of NorthRock Partners's portfolio in Q1 2026, its #662 holding.
- NorthRock Partners first reported a position in Ambev in Q3 2025 and has held it in 3 quarters since.
- 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.
Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.